ReviewCurrent treatment options in oncology2024

Looking Beyond the Surface: Olutasidenib and Ivosidenib for Treatment of mIDH1 Acute Myeloid Leukemia.

Justin M Watts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.